Insiders · Profile

Colleran David

EVP, General Counsel, Corp Sec at Anika Therapeutics · SVP, Secretary and GC at Insulet. Filing since 15 May 2018. CIK 0001646558

Company
Date
Role
Action
Shares
Amount
Of holding
11 May 2022
EVP, General Counsel, Corp Sec
Bought
1,500
$32.06K
17.9%
14 Mar 2022
EVP, General Counsel, Corp Sec
Bought
1,500
$39.98K
21.8%
2 Apr 2019
SVP, Secretary and GC
Sold, plan not stated
7,395
$701.71K
19.5%
1 Mar 2019
SVP, Secretary and GC
Sold, plan not stated
20,975
$1.99M
40.8%
5 Feb 2019
SVP, Secretary and GC
Sold, plan not stated
6,834
$551.64K
16.7%
31 Jan 2019
SVP, Secretary and GC
Sold, plan not stated
4,826
$386.08K
12.4%
14 Nov 2018
SVP, Secretary and GC
Sold, plan not stated
6,113
$491.55K
15.2%
15 May 2018
SVP, Secretary and GC
Sold, plan not stated
4,956
$427.41K
11.8%
8 decisions on file.